title: Why, when, and how often?: The next steps after defining the right tools for noninvasive imaging of cardiotoxicity.
authors.affiliation: Menzies Research Institute Tasmania, Hobart, Australia.
authors.forename: Thomas H
authors.initials: TH
authors.lastname: Marwick
authors.affiliation: Icahn School of Medicine at Mount Sinai, New York, New York. Electronic address: jagat.narula@mountsinai.org.
authors.forename: Jagat
authors.initials: J
authors.lastname: Narula
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects*; D002318:Cardiovascular Diseases / Q000175:diagnosis*; D003952:Diagnostic Imaging / Q000379:methods*; D006801:Humans; D009369:Neoplasms / Q000628:therapy*; D011832:Radiation Injuries / Q000175:diagnosis*
chemical_list: D000970:Antineoplastic Agents